Agenda
Download Annual Meeting Agenda PDF
Thursday, May 16
Eastern Daylight Time
| 7:00-8:00 AM | Breakfast and Registration |
| 8:00 AM-11:20 AM | Spondyloarthritis Review Course |
| 11:20-12:15 PM | LUNCH (for Spondyloarthritis Review Course attendees only) |
| 12:15-3:15 PM | Ultrasound Imaging Workshop |
| 5:30-7:00 PM | Welcome Reception and Poster Session |
| 7:00-9:00 PM | Sponsor Forum (by invitation) |
Friday, May 17
Eastern Daylight Time
| 7:00-8:00 AM | Breakfast for Annual Meeting attendees REFRESH Breakfast for interested early career investigators, trainees, or spondy newbies |
| 8:00-8:10 AM | Welcome Joerg Ermann, MD, Brigham and Women’s Hospital, Boston, Massachusetts |
| 8:10-8:20 AM | SPARTAN Research Career Achievement Award |
| 8:20-10:00 AM | SESSION I: Year in Review Moderators: Marina Magrey, MD and Jean Liew, MD, MS |
| Basic Science Akihiro Nakamura, MD, PhD, Queen’s University, Ontario, Canada |
|
| Clinical Trials Jonathan Kay, MD, UMass Memorial Health, Worcester, Massachusetts |
|
| Clinical Research (Non-clinical Trial) and Imaging Mohamad Bittar, MD, OHSU, Portland, Oregon |
|
| 9:50-10:10 AM | BREAK |
| 10:10-12:00 PM | SESSION II: Spondyloarthritis Classification, Sub- and Endotypes Moderators: Nigil Haroon, MD, PhD and Mark Hwang, MD |
| Past, Present and Future of the SpA Concept Jürgen Braun, MD, Ruhr University Bochum, Bochum, Germany |
|
| Big Data: Artificial Intelligence and Machine Learning to Help Identify Endotypes and Study Outcomes Bo Wang, PhD, University Health Network, Toronto, Canada |
|
| Essential Concepts for the Development of Classification Criteria Sindhu Johnson, MD, PhD, FRCPC, University of Toronto, Toronto, Canada |
|
| 12:00-12:45 PM | LUNCH |
| 12:45-2:30 PM | SESSION III: Spondyloarthritis Management in 2024 and Beyond Moderators: Matt Stoll, MD, PhD and Vikas Majithia, MD |
| Unraveling the Challenges of Difficult-to-Treat Spondyloarthritis Fabian Proft, MD, Charité Universitätsmedizin Berlin, Berlin, Germany |
|
| Rationale, Indications and Safety of Dual Biologic Therapy Simon Hong, MD, NYU Langone Health, New York, New York |
|
| Spondyloarthritis in Focus: Pediatric Developments and Cutting-Edge Treatment Modalities Hemalatha Srinivasalu, MD, Children’s National, Washington DC |
|
| 2:30-3:10 PM | Breakout Sessions |
| 3:10-3:30 PM | BREAK |
| 3:30-4:30 PM | Abstracts and Grants Moderators: John Reveille, MD and Ruth Napier, PhD |
| Transcriptional and Epigenetic Analysis of Gut-Joint Trafficked T cells Suggest Regulatory Functions during Homeostasis Sarah Danielson, University of Colorado, Denver, Colorado |
|
| Nonsteroidal Anti-Inflammatory Drug Use and Incident Hypertension among Patients with Axial Spondyloarthritis: Insights from the DESIR Cohort Jose A. Meade-Aguilar, MD, Boston University, Boston, Massachusetts |
|
| The Added Utility of Hybrid Positron Emission Tomography-Magnetic Resonance (PET-MR) Imaging over Magnetic Resonance Imaging (MRI) Alone in Diagnosing Axial Spondyloarthritis Patricia Remalante-Rayco, MD, Schroeder Arthritis Institute, University Health Network, Toronto, Canada |
|
| Clarifying the Toolkit for Pain Control in Spondyloarthritis with IBD: Association of Prescription NSAID use with IBD-related Hospitalization, a Retrospective Analysis across the Age Spectrum Adam Mayer, MD, Children’s Hospital of Philadelphia/University of Pennsylvania, Philadelphia, Pennsylvania |
|
| 4:30-6:00 PM | SPARTAN Projects Moderators: Maureen Dubreuil, MD, MSc and Jessica Walsh, MD |
| BASIS Elaine Husnie, MD, MPH, Cleveland Clinic, Cleveland, Ohio; Sibel Aydin, MD, University of Ottowa, Ottowa, Canada |
|
| Referral Recommendations Abhijeet Danve, MBBS, MD, MHS, Yale University, New Haven, Connecticut |
|
| ACR/SPARTAN/SAA Guidelines Liron Caplan, MD, PhD, University of Colorado, Denver, Colorado |
|
| SpA Screening in IBD—GRASp-IBD Study Reem Jan, MD, MBBS, University of Chicago, Chicago, Illinois |
|
| Sex Differences in axSpA Lihi Eder MD, PhD, University of Toronto, Toronto, Canada |
|
| 7:00-9:30 PM | Dinner at the Cleveland Museum of Natural History |
Saturday, May 18
Eastern Daylight Time
| 7:00-8:00 AM | Breakfast |
| 8:00-9:00 AM | Keynote Address Moderators: Judith Smith, MD, PhD and Siba Raychaudhuri, MD |
| Discovery of the JAK/STAT Pathway and Development of Therapies Targeting This Pathway John O’Shea, MD, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland |
|
| 9:00-11:15 AM | CLASSIC Moderator: Lianne Gensler, MD Walter Maksymowych, MD, FRCP, FACP, University of Alberta |
| 11:15-11:35 AM | BREAK |
| 11:35-12:00 PM | Breakout Session Reports |
| 12:00-1:00 PM | The Great Debate Moderator: Maureen Dubreuil, MD, MSc |
| Is axSpA an Autoimmune Disease? Robert Colbert, MD, PhD, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland Kristi Kuhn, MD, PhD, University of Colorado, Denver, Colorado |
|
| 1:00 PM | LUNCH |
